Opioid Abuse
47
4
5
28
Key Insights
Highlights
Success Rate
85% trial completion
Published Results
17 trials with published results (36%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
10.6%
5 terminated out of 47 trials
84.8%
-1.7% vs benchmark
17%
8 trials in Phase 3/4
61%
17 of 28 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 28 completed trials
Clinical Trials (47)
Neuromodulation and Cognitive Training in Opioid Use Disorder
Community Trial in the Cherokee Nation
Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool
Opioid/Benzodiazepine Polydrug Abuse: Aim 3
Rural Expanded Access to OUD Care & Linkage Using Toxicologists for Telehealth Initiated Treatment
fMRI and Opioid Abstinence
AESOPS Trial 2 (AESOPS-2): Availability of Opioid Harm
Buprenorphine Induction and Naloxone Distribution Program-Combined With Warm Hand-Off Referral to Continued Treatment
Oral Abuse Potential Study of Nalbuphine
OLP to Manage Pain in TJA: A Feasibility Study
PRescribing INterventions for Chronic Pain Via the Electronic Health Record Study - Current Opioid-User Population
Opioid Education in Total Knee Arthroplasty
Implementing Screening for Cannabis and Other Drug Use Disorders in Primary Care: Impact on Diagnosis and Treatment
PRescribing INterventions for Chronic Pain Via the Electronic Health Record Study - Opioid-Naive Population
Novel Induction to Buprenorphine/Naloxone
Ketamine for the Treatment of Opioid Use Disorder and Depression
Validation of a Community Pharmacy-Based Prescription Drug Monitoring Program Risk Screening Tool
PRescribing INterventions for Chronic Pain Via the Electronic Health Record Study - Primary Care Providers
Opioid Reduction Toolkit Reduces Opioids Prescribed and Consumed
A Project to Test the Efficacy and Safety of An Innovative Treatment for Opiate Use Disorders.